Skip to main content

Notifications

Alert

Monkeypox vaccine available for eligible ICHS patients at high risk. Please call an ICHS clinic to determine eligibility and make an appointment.

Information

Pfizer COVID-19 bivalent (Omicron) boosters are now available for everyone ages 5+! ICHS patients call (206) 788-3700 for appointments. Non-ICHS patients walk-in to our pharmacies Monday-Friday from 9am-4pm (supplies limited) at our International District, Holly Park, and Shoreline clinics. More info on our COVID-19 vaccine page.

Alert

Masks are mandatory at all ICHS clinics and sites. ICHS is a health care facility. Please keep yourself and others safe.

CDC recommends use of Johnson & Johnson’s Janssen COVID-19 vaccine resume

CDC recommends use of Johnson & Johnson’s Janssen COVID-19 vaccine resume

Published
April 26, 2021
P1011726-scaled-e1618423033323

On April 23, the CDC and the U.S. Food and Drug Administration (FDA) recommend use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine resume in the United States, after a temporary pause.

Reports of adverse events following the use of J&J/Janssen vaccine suggest an increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS). Nearly all reports of this serious condition, which involves blood clots with low platelets, have been in adult women younger than 50 years old.

A review of all available data at this time shows that the J&J/Janssen COVID-19 vaccine’s known and potential benefits outweigh its known and potential risks. However, women younger than 50 years old should be aware of the rare but increased risk of this adverse event and that there are other COVID-19 vaccine options available for which this risk has not been seen. ICHS has been delivering Moderna COVID-19 vaccines since Dec. 2020 and Janssen vaccines since March 2021. ICHS also began administering Pfizer vaccines on April 23 at its Bellevue clinic.

CDC and FDA will continue to monitor the safety of all COVID-19 vaccines. Seek medical care right away if you develop any of the symptoms below after receiving the J&J/Janssen COVID-19 vaccine. For three weeks after receiving the vaccine, you should be on the lookout for possible symptoms of a blood clot with low platelets. These include:

  • Severe or persistent headaches or blurred vision
  • Shortness of breath
  • Chest pain
  • Leg swelling
  • Persistent abdominal pain
  • Easy bruising or tiny blood spots under the skin beyond the injection site

Seek medical care right away if you develop one or more of these symptoms.

For the most recent updates, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html 

For ICHS’ vaccine frequently asked questions page, please click here.


Additional resources

Visit the Public Health – Seattle & King County website for the latest information and updates about vaccine development and distribution.

COVID-19 Vaccines | CDC

Vaccine Information: Washington State Department of Health

COVID-19 Vaccines | FDA

_7R44445_cropped

Keep in Touch!

Join our mailing list to stay up-to-date on ICHS news and stories

_A644662_cropped